Author

M. Olivier

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 3 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Research Focus:variant calling· 2 Research Focus:variant effect prediction· 2 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1

Frequent Co-Authors

A. Heguy· 2 shared S. Villar· 2 shared A. Boot· 1 shared A. C. Rodriguez· 1 shared A. Descoteaux· 1 shared A. Jusakul· 1 shared A. Lametti· 1 shared A. Ng· 1 shared

Activity by Year

2017-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. Heguy

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

BCG administration promotes the long-term protection afforded by a single-dose intranasal adenovirus-based SARS-CoV-2 vaccine

D. J. Perera, P. Domenech, G. G. Babuadze, M. Naghibosadat, F. Alvarez, C. Koger-Pease, L. Labrie, M. Stuible, Y. Durocher, C. A. Piccirillo, A. Lametti, P. O. Fiset, S. M. Elahi, G. P. Kobinger, R. Gilbert, , M. Ndao

BCG enhances anti-SARS-CoV-2 immunity and protection afforded by a novel adenovirus-vectored vaccine.

bioRxiv · Mar 21, 2023Immunology

Revisiting Leishmania GP63 host cell targets reveals a limited spectrum of substrates

M.-M. Guay-Vincent, C. Matte, A.-M. Berthiaume, M. Olivier, M. Jaramillo, A. Descoteaux

This study re-examines GP63 substrates in Leishmania-infected macrophages by inhibiting GP63 activity during lysate preparation, revealing a limited set of genuine substrates.

bioRxiv · Jun 6, 2022Microbiology

Molecular features of premenopausal breast cancers in Latin American women: pilot results from the PRECAMA study

M. Olivier, L. Bouaoun, S. Villar, A. Robitaille, V. Cahais, A. Heguy, G. Byrnes, F. Le Calvez-Kelm, G. Torres-Mejia, I. Alvarado-Cabrero, F. S. Imani-Razavi, G. Ines Sanchez, R. Jaramillo, C. Porras, A. C. Rodriguez, , S. Rinaldi

The paper characterizes molecular features of premenopausal breast cancers in Latin American women using genomic and immunohistochemical analyses, finding distinct mutational patterns in TP53 and exome-wide signatures compared to other populations.

PLOS ONE · Jan 17, 2019Peer-reviewedCancer Biology

Genome-Scale Mutational Signatures Of Aflatoxin In Cells, Mice And Human Tumors

M. N. Huang, W. Yu, W. W. Teoh, M. Ardin, A. Jusakul, A. Ng, A. Boot, B. Abedi-Ardekani, S. Villar, S. S. Myint, R. Othman, S. L. Poon, A. Heguy, M. Olivier, M. Hollstein, , S. Rozen

This study identifies AFB1 mutational signatures across multiple systems and shows their prevalence in HCCs from different regions, highlighting aflatoxin's public health impact.

bioRxiv · Apr 26, 2017Cancer Biology